Subsequent pregnancy outcome in patients with molar pregnancy and gestational trophoblastic tumors.
Subsequent pregnancy outcome was reviewed in patients with complete and partial mole and persistent gestational trophoblastic tumors who were treated at the New England Trophoblastic Disease Center between Jun 1, 1965, and Dec 31, 1986. In general, these patients can be reassured that they can anticipate a normal reproductive outcome in the future.
Berkowitz
R S
RS
New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Brigham and Women's Hospital, Boston, MA 02115.
Goldstein
D P
DP
Bernstein
M R
MR
Sablinska
B
B
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000628:therapy; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology; D011256:Pregnancy Outcome; D014328:Trophoblastic Neoplasms / Q000517:prevention & control / Q000628:therapy*; D014594:Uterine Neoplasms / Q000517:prevention & control / Q000628:therapy*
D000970:Antineoplastic Agents